Resources

Type of publications
Regions
Diseases

5192 results found

2025 ∙ Phiri, W. W. Kazonga, E. Lubemba, F. Kangwa, G. M. Sakala, L. Banda, M.

Effectiveness of Community-Based Interventions in Reducing Vaccine Hesitancy and Improving COVID-19 Vaccinations Coverage in Developing Countries: A Systematic Review

  • Adults
  • Older adults
  • Low and Middle Income Countries
  • COVID-19
  • Coverage
Methodological quality (AMSTAR 2):
Not applicable
2025 ∙ Peine, C. Stoliaroff-Pepin, A. Reinacher, U. Heldt, K. Sarganas, G. Piechotta, V. Mikolajewska, A. Pilic, A. Barkowski, N. Bleve, D. Giebeler, M. H. Poser, S. Searle, L. Kissner, E. Nitsche, L. Bayram, F. Siemens, W. Ziegler, A. Meerpohl, J. J. Sandmann, F. Wichmann, O. Harder, T.

Effectiveness of COVID-19 vaccines against post-COVID-19 condition/long COVID: systematic review and meta-analysis

  • All age groups
  • COVID-19
  • Efficacy/effectiveness
  • Administration
Methodological quality (AMSTAR 2):
High
2025 ∙ Zhou, G. Dael, N. Verweij, S. Balafas, S. Mubarik, S. Rengerink, K. O. Pasmooij, A. M. G. van Baarle, D. Mol, P. G. M. de Bock, G. H. Hak, E.

Effectiveness of COVID-19 vaccines against SARS-CoV-2 infection and severe outcomes in adults: a systematic review and meta-analysis of European studies published up to 22 January 2024

  • Europe
  • Adolescents
  • Adults
  • COVID-19
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2025 ∙ Alqahtani, M. S. Hamed, N. F. Alhowity, E. Alomogren, F. A. Alkhaldi, D. M. Alanazi, F. K. M. Kaddoura, A.

Effectiveness of Influenza Vaccination against Influenza-related Hospitalizations among Children: A Systematic Review

  • Newborn
  • Children
  • Adolescents
  • Influenza
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2025 ∙ S, A. K. Wasnik, A. Gupta, L. Ranjan, A. Suresh, H.

Effectiveness of interventions to improve vaccine efficacy: a systematic review and meta-analysis

  • All age groups
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Not applicable
2025 ∙ Bulkhi, A. Khadawardi, H. A. Dairi, M. S. Alwafi, H. Alim, H. M. Turkistani, Y. A. Almoallim, H. M. Alghamdi, I. A. Alqashqri, H. S. Obaid, M. S. Alkhotani, A. M. A. Alhazmi, A. S. H. Adly, H. M. Zaini, R. Abdulkhaliq, A. A. Saleh, S. A. K. Hariri, N. H. Khan, A. A. Alamri, F. A. Garout, M. A.

Effectiveness of pneumococcal vaccination in reducing hospitalization and mortality among the elderly: A systematic review and meta-analysis

  • Adults
  • Older adults
  • Pneumococcal disease
  • Efficacy/effectiveness
  • Administration
Methodological quality (AMSTAR 2):
Low
2025 ∙ Chen, S. Wang, S. Cheung, D. H. Fang, Y. Sun, F. Mo, P. K. H. Wang, Z.

Effectiveness of stage-of-change (SOC)-tailored interventions in increasing uptake of any type of vaccination: A systematic review and meta-analysis

  • All age groups
  • Coverage
  • Acceptance
Methodological quality (AMSTAR 2):
Not applicable
2025 ∙ Ma, H. Chen, Y. Y. Shih, W. L. Chen, Y. C. Chen, T. J. Fang, C. T.

Effectiveness of the monovalent XBB.1.5 COVID-19 vaccines: A systematic review and meta-analysis

  • Adults
  • Older adults
  • COVID-19
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2025 ∙ Pelzer, P. T. Stuck, L. Martinez, L. Richards, A. S. Acuna-Villaorduna, C. Aronson, N. E. Bonnet, M. Carvalho, A. C. Chan, P. C. Huang, L. M. Fang, C. T. Churchyard, G. Corral-Londono, H. D. Datta, M. Espinal, M. A. Fielding, K. Fiore-Gartland, A. J. Garcia-Basteiro, A. Hanekom, W. Hatherill, M. Hill, P. C. Huerga, H. Jones-Lopez, E. C. Kritski, A. Mandalakas, A. M. Mangtani, P. Martins Netto, E. Mayanja, H. Mazahir, R. Murray, M. Rangaka, M. Scriba, T. Singh, J. Singh, S. Stein, C. M. Vekemans, J. Verhagen, L. M. Villalba, J. A. Wajja, A. Watson, B. White, R. G. Cobelens, F. G. J.

Effectiveness of the primary Bacillus Calmette-Guerin vaccine against the risk of Mycobacterium tuberculosis infection and tuberculosis disease: a meta-analysis of individual participant data

  • All age groups
  • Tuberculosis
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2025 ∙ Chang, C. Y. Nasreen, S. Sadarangani, M. Aquino, K. Cragg, J. J. Marra, F.

Effectiveness of vaccine dosing schedules for pneumococcal invasive disease in children: A systematic review and meta-analysis

  • Newborn
  • Children
  • Adolescents
  • Pneumococcal disease
  • Efficacy/effectiveness
  • Administration
Methodological quality (AMSTAR 2):
Low
Loading...